News
Learn how to enable fluid sharing of molecules and results between computational and medicinal chemists in our upcoming #webinar in collaboration with @cressetgroup hubs.ly/Q01k8vhQ0 #drugdesign #drugdiscovery #pharma #medchem #compchem #biotech #CADD pic.twitter.com/3nYN8JHmDv
Our ‘A day in the life of a chemist’ series will explore different aspects of a ‘typical’ day for chemists ...
In our product highlight 'Small molecule, big platform' (DDN, June 2022), learn how Torx® brings drug discovery into the digital era. ...
The analysis of new assay data is integral to making the right design decisions in the Design-Make-Test-Analyze (DMTA) cycle. Combining this ...
2021 has been a significant year in the life of Torx™ with the launch of the final two modules, Torx ...
In drug discovery, all newly synthesized small molecules must undergo first pass profiling through multiple assays to define SAR and ...
Cambridge, UK – 21 October 2021 – Torx Software Limited, provider of technology for managing small molecule discovery chemistry, announces ...
We are delighted to announce the release of the final modules of Torx™, your platform for small molecule discovery chemistry:
Discovery chemistry has progressed significantly in recent years. Researchers now have an abundance of information available to them, from computational ...
The ubiquitous Design-Make-Test-Analyze (DMTA) cycle provides a conerstone for drug discovery teams to consider and improve productivity. The challenge is ...
The delivery of synthesis targets within drug discovery often involves chemists from different organizations. Engaging contract research organization (CRO) partners ...
Chemistry teams working in small molecule discovery follow an iterative Design-Make-Test-Analyze (DMTA) cycle to design and optimize new therapeutics. Companies ...
Torx Design™ is a cloud-based platform that provides a central location to capture and share information about molecules, hypotheses and ...
